期刊文献+

中晚期肺癌伴肺真菌感染临床分析及肿瘤标志物表达水平观察 被引量:10

Clinical analysis of moderate-advanced lung cancer complicated with pulmonary fungal infection and observation of expression levels of tumor markers
暂未订购
导出
摘要 目的探讨肺癌及并发肺部真菌感染的发病原因、诊断和治疗。方法 110例肺癌患者(肺癌组)中20例患者合并肺部真菌感染,随机抽取45例同期健康体检者为对照组。对肺癌伴肺真菌感染患者的症状、痰培养、影像学诊断、抗生素、激素等使用情况进行分析。检测所有患者血清肿瘤标志物CEA、CA125、CYFRA21-1、NSE水平。结果 20例肺部真菌感染患者中,曾经化疗者18例,反复使用过广谱抗生素治疗者18例,使用过激素者12例。肺癌组血清CEA、CA125、CYFRA21-1、NSE水平均明显高于对照组(P<0.01);4项肿瘤标志物联合检测灵敏度及准确性均高于单一检测。结论肺癌合并肺部真菌感染原因与化疗、体质差、大量广谱抗生素的反复应用、激素应用等有关,应及早行病原学检查,足量强效抗真菌治疗,并达到病原学完全缓解。CEA、CA125、CYFRA21-1、NSE对肺癌血清学诊断具有重要意义。 Objective To explore causes,diagnosis and treatment of lung cancer complicated with pulmonary fungal infection.Methods Twenty out of 110 patients with lung cancer(lung cancer group) were complicated with pulmonary fungal infection.Another 45 healthy subjects at the same period were randomly selected as the control group.The symptoms of lung cancer patients complicated with pulmonary fungal infection,sputum culture,radiographic diagnosis,the usage of antibiotics and hormones were analyzed.Serum tumor markers such as CEA,CA125,CYFRA21-1 and NSE level were detected in all the patients.Results Among those 20 patients,18 underwent chemotherapy, 18 had repeated intake of broad-spectrum antibiotics,and 12 used hormones.The serum CEA,CA125,CYFRA21-1 and NSE levels were significantly higher in the cancer group(P 0.01) than in the control group.The combined detection of the 4 tumor marker were of higher sensitivity and accuracy than the single detection.Conclusion Occurrence of lung cancer complicated by pulmonary fungal infection is related to chemotherapy,weak physical constitution,repeated intake of broad-spectrum antibiotics and hormones.The patients should be examined earlier with etiology and given adequate anti-fungal treatment to achieve complete remission from an etiologic perspective.CEA,CA125,CYFRA21-1 and NSE are of great importance to the serological diagnosis of lung cancer.
出处 《实用临床医药杂志》 CAS 2012年第7期102-103,109,共3页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11220023)
关键词 肺癌 真菌感染 肿瘤标志物 lung cancer fungal infection tumor markers
  • 相关文献

参考文献7

  • 1吴莉萍.血清CEA、CYFRA21-1、NSE、CA125联检在肺癌中的诊断价值[J].放射免疫学杂志,2011,24(6):696-697. 被引量:1
  • 2Verbeek A L, van Dijck J A, Kiemency L A, ctal. Responsi- ble cancer screening[J]. Ned Tijdschr Geneeskd, 2011, 155 (45) : A3934.
  • 3黄纯,王璇.晚期肺癌并发肺部真菌感染的临床分析[J].临床肿瘤学杂志,2008,13(1):23-25. 被引量:5
  • 4陈文彬.深部真菌感染病原学诊断概述[J].中国实用内科杂志,2002,22(1):5-6. 被引量:89
  • 5Bradsher RW Jr. Pulmonavy blastomycosis [J]. Semin Respir Crit Care Med, 2008, 29(2) : 174.
  • 6Ben - Ami R, Lewis R E, Tarrand J, et al. Antifungal activity of' colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae puhnonary infection [ J]. Antimicrob Agents Chemother, 2010, 54( 1 ) : 484.
  • 7Molina R, Filella X, Auge JM, et al. Tumor markers (CEA, CA 125, CYFRA 21 -1, SCC and NSE) in patients with non - small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors [ J ]. Tumour Biol, 2003, 24 (4) : 209.

二级参考文献9

  • 1卢建平,张翊.医院内真菌感染临床分析[J].中华医院感染学杂志,2004,14(3):344-346. 被引量:95
  • 2姜愚,李俊英,李梅,周麟,彭枫,魏于全.癌症患者院内肺部真菌感染的临床分析[J].癌症,2004,23(12):1707-1709. 被引量:26
  • 3Stieber P,Hasholzner U,Bodenmuller H et al.CYFRA21-1,a new marker in lung cancer[J].Cancer,1993,72(3):707 -713.
  • 4Mitsuhashi N,Takahashi T,Sakruai H,et al.Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line,GⅡ-1 producing carcinoembryonic antigen(CEA) and CA19-9[J].Lung Cancer,1995,12:13.
  • 5Miedouge M,Dcvy A,Simon M,et al.High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1,2,10,1 1,14 or filaggrin in the serum of squamous cell lung carcinoma patients[J].Tumor Biol,2001,22:19-26.
  • 6Nakata B,Chung YS,Karo Y,et al.Clinical significance of serum CYFRA21-1 in gastriccancer[J].Br J Cancer,1996,73(12):1529-1532.
  • 7Ebert W,Muley T,Dfing P.Does the asessment of serum markers in patients with lung cancer aid in the clinical decision making process[J].Anticancer Res,1996,16(4B):2161-2168.
  • 8Berthiot G.Serum levels of CA50,CA19-9,neuron specific enolase and carcinoembrogonic antigen in lung cancer and benign disease of the lung[J].Biomed-pharmacothre,1989,43(8):613.
  • 9王英,黄文成,黄玲莎.血清肿瘤标志物联合检测在恶性肿瘤诊断中的临床应用[J].现代肿瘤医学,2004,12(2):145-146. 被引量:35

共引文献92

同被引文献87

引证文献10

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部